Tag: Pfizer
Pfizer: Stake in Haleon will be reduced to 24%
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer: Green light to market Prevenar 20 in the EU
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer: Eight oncology blockbusters planned by 2030
Read also (CercleFinance.com) – Pfizer estimated on Thursday that it had a ‘robust’ portfolio of drugs in oncology since the finalization of the acquisition of Seagen at the end of…
Pfizer pays $93 million in Lipitor case
(AOF) – Pfizer has agreed to pay $93 million to settle its dispute with wholesale drug distributors who accused it of colluding with Indian laboratories Ranbaxy to delay sales of…
Pfizer: Partners with UT Southwestern Medical Center
(CercleFinance.com) – UT Southwestern Medical Center is partnering with Pfizer Inc. to develop RNA-enhanced delivery technologies for genetic medicine therapies through the UT Southwestern Medical Center’s Genetic Drug Engineering Program.…
Pfizer: Extended collaboration with Saama in AI
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer: application accepted in cervical cancer
(CercleFinance.com) – Pfizer and the Danish company Genmab announced on Friday that the European Medicines Agency (EMA) had validated the marketing authorization application for their new treatment for cervical cancer.…
Johnson & Johnson: The stock falls behind Pfizer and an analyst note
Read also (CercleFinance.com) – Johnson & Johnson suffered the second biggest drop in the Dow Jones index on Wednesday, penalized by the disappointing forecasts revealed by Pfizer and by a…
Pfizer: ‘Encouraging’ data in breast cancer
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer abandons development of obesity treatment
Published on 01/12/2023 at 3:02 p.m. Photo credit © Reuters (Reuters) – Pfizer will abandon development of…
Pfizer: Mixed data from a trial in obesity
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Pfizer abandons twice-daily formula of weight-loss drug – 01/12/2023 at 2:13 p.m.
(AOF) – Pfizer is expected to fall sharply in the pre-market on Wall Street after announcing that it would not move danuglipron, an oral weight loss medication, to the final…